MUDr. Petra Prvni s.r.o.

The trial assesses how Saccharomyces boulardii influences gut microbiota in patients receiving antibiotic therapy for erythema migrans, the early skin manifestation of Lyme borreliosis.

• Probiotic modulation of the microbiome
• Prevention of antibiotic‑associated dysbiosis
• Supportive care in early Lyme disease

MUDr. Petra Prvni s.r.o. in Radomysl is conducting this research to improve outcomes for patients undergoing treatment for tick‑borne infections while preserving digestive health.

The study compares the efficacy of ibuzatrelvir with placebo in non‑hospitalized COVID‑19 patients who are at high risk of severe illness, aiming to reduce disease progression.

• Evaluation of oral antiviral agents
• Outpatient management strategies for COVID‑19
• Risk stratification for severe viral disease

At MUDr. Petra Prvni s.r.o., researchers are focused on advancing therapeutic options that can keep high‑risk individuals out of the hospital and lessen the impact of the pandemic.